logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Teleflex finalizes acquisition of Biotronik's business

Jul 02, 2025•6 months ago

Acquiring Company

Teleflex Incorporated

Acquired Company

BIOTRONIK

WayneBerlinBiotechnologyHealth CareMedical DeviceMedicalManufacturing

Description

Teleflex has completed the acquisition of Biotronik's vascular intervention business for $895 million. This acquisition enables Teleflex to enhance its clinical trial program and expand its innovative product offerings in the cath lab. The deal aims to improve patient care and strengthen Teleflex's global presence. The completion was announced earlier than expected by Teleflex's CEO, Liam Kelly.

Company Information

Company

Teleflex Incorporated

Location

Wayne, Pennsylvania, United States

About

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com. Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed